Immunological priming requires regulatory T Cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation

Journal of Immunology

Volumn 192, Issue 9, 2014, Pages 4453-4464

  Aggarwal, Neil R ^a   Tsushima, Kenji ^a   Eto, Yoshiki ^a   Tripathi, Ashutosh ^a   Mandke, Pooja ^a   Mock, Jason R ^a   Garibaldi, Brian T ^a   Singer, Benjamin D ^a   Sidhaye, Venkataramana K ^a   Horton, Maureen R ^a   King, Landon S ^a   D'Alessio, Franco R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGONUCLEOTIDE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPLETION; DISEASE SEVERITY; IMMUNOLOGICAL PRIMING; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS INHIBITION; PSEUDOMONAS; REGULATORY T LYMPHOCYTE;

ANIMALS; CYTOKINES; FLOW CYTOMETRY; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA; T-LYMPHOCYTES, REGULATORY; VACCINATION;

EID: 84899542322     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400146     Document Type: Article

References (86)

1. Romero, C. D., T. K. Varma, J. B. Hobbs, A. Reyes, B. Driver, and E. R. Sherwood. 2011. The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection. Infect. Immun. 79: 3576-3587
2. Meldrum, D. R., J. C. Cleveland, Jr., E. E. Moore, D. A. Partrick, A. Banerjee, and A. H. Harken. 1997. Adaptive and maladaptive mechanisms of cellular priming. Ann. Surg. 226: 587-598
3. Ariel, A., I. Maridonneau-Parini, P. Rovere-Querini, J. S. Levine, and H. Muhl. 2012. Macrophages in inflammation and its resolution. Front. Immunol. 3: 324
4. Bem, R. A., A. W. Farnand, V. Wong, A. Koski, M. E. Rosenfeld, N. Van Rooijen, C. W. Frevert, T. R. Martin, and G. Matute-Bello. 2008. Depletion of resident alveolar macrophages does not prevent Fas-mediated lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L314-L325
5. Doherty, D. E., G. P. Downey, G. S. Worthen, C. Haslett, and P. M. Henson. 1988. Monocyte retention and migration in pulmonary inflammation: Requirement for neutrophils. Lab. Invest. 59: 200-213
6. Herold, S., K. Mayer, and J. Lohmeyer. 2011. Acute lung injury: How macrophages orchestrate resolution of inflammation and tissue repair. Front. Immunol. 2: 65
7. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852
8. Thepen, T., N. Van Rooijen, and G. Kraal. 1989. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 170: 499-509
9. Latz, E., A. Visintin, E. Lien, K. A. Fitzgerald, B. G. Monks, E. A. Kurt-Jones, D. T. Golenbock, and T. Espevik. 2002. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277: 47834-47843
10. Fujihara, M., M. Muroi, K. Tanamoto, T. Suzuki, H. Azuma, and H. Ikeda. 2003. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: Roles of the receptor complex. Pharmacol. Ther. 100: 171-194
11. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: New mechanisms, molecules and clinical significance. Trends Immunol. 30: 475-487
12. Döcke, W. D., F. Randow, U. Syrbe, D. Krausch, K. Asadullah, P. Reinke, H. D. Volk, and W. Kox. 1997. Monocyte deactivation in septic patients: Restoration by IFN-g treatment. Nat. Med. 3: 678-681
13. Volk, H. D., P. Reinke, and W. D. Döcke. 2000. Clinical aspects: From systemic inflammation to immunoparalysis. Chem. Immunol. 74: 162-177
14. Draisma, A., R. Bemelmans, J. G.Van Der Hoeven, P. Spronk, and P. Pickkers. 2009. Microcirculation and vascular reactivity during endotoxemia and endotoxin tolerance in humans. Shock 31: 581-585
15. Draisma, A., P. Pickkers, M. P. Bouw, and J. G.Van Der Hoeven. 2009. Development of endotoxin tolerance in humans in vivo. Crit. Care Med. 37: 1261-1267
16. Tighe, R. M., J. Liang, N. Liu, Y. Jung, D. Jiang, M. D. Gunn, and P. W. Noble. 2011. Recruited exudative macrophages selectively produce CXCL10 after noninfectious lung injury. Am. J. Respir. Cell Mol. Biol. 45: 781-788
17. Lin, K. L., Y. Suzuki, H. Nakano, E. Ramsburg, and M. D. Gunn. 2008. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenzainduced pulmonary immune pathology and mortality. J. Immunol. 180: 2562-2572
18. Asadullah, K., R. Sabat, M. Friedrich, H. D. Volk, and W. Sterry. 2004. Interleukin-10: An important immunoregulatory cytokine with major impact on psoriasis. Curr. Drug Targets Inflamm. Allergy 3: 185-192
19. Asadullah, K., W. Sterry, and H. D. Volk. 2003. Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55: 241-269
20. Moore, K. W., R. De Waal Malefyt, R. L. Coffman, and A. O?Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765
21. Smith, D. R., S. L. Kunkel, M. D. Burdick, C. A. Wilke, M. B. Orringer, R. I. Whyte, and R. M. Strieter. 1994. Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol. 145: 18-25
22. Berg, D. J., R. Kuhn, K. Rajewsky, W. Muller, S. Menon, N. Davidson, G. Grunig, and D. Rennick. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96: 2339-2347
23. Lang, R., D. Patel, J. J. Morris, R. L. Rutschman, and P. J. Murray. 2002. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169: 2253-2263
24. Buff, S. M., H. Yu, J. N. McCall, S. M. Caldwell, T. W. Ferkol, T. R. Flotte, and I. L. Virella-Lowell. 2010. IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther. 17: 567-576
25. D?Alessio, F. R., K. Tsushima, N. R. Aggarwal, E. E. West, M. H. Willett, M. F. Britos, M. R. Pipeling, R. G. Brower, R. M. Tuder, J. F. McDyer, and L. S. King. 2009. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Invest. 119: 2898-2913
26. Michlewska, S., I. Dransfield, I. L. Megson, and A. G. Rossi. 2009. Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: Key role for TNF-a. FASEB J. 23: 844-854
27. Rubtsov, Y. P., J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson, Jr., et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558
28. Byrne, A., and D. J. Reen. 2002. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J. Immunol. 168: 1968-1977
29. Gerber, J. S., and D. M. Mosser. 2001. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcg receptors. J. Immunol. 166: 6861-6868
30. Kim, K. D., J. Zhao, S. Auh, X. Yang, P. Du, H. Tang, and Y. X. Fu. 2007. Adaptive immune cells temper initial innate responses. Nat. Med. 13: 1248-1252
31. Liu, G., H. Ma, L. Qiu, L. Li, Y. Cao, J. Ma, and Y. Zhao. 2011. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol. Cell Biol. 89: 130-142
32. Tiemessen, M. M., A. L. Jagger, H. G. EVans, M. J. Van Herwijnen, S. John, and L. S. Taams. 2007. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA 104: 19446-19451
33. Taams, L. S., J. M. Van Amelsfort, M. M. Tiemessen, K. M. Jacobs, E. C. De Jong, A. N. Akbar, J. W. Bijlsma, and F. P. Lafeber. 2005. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. Immunol. 66: 222-230
34. Akilov, O. E., M. X. Wu, Y. Jin, Z. Zhou, L. J. Geskin, L. D. Falo, and T. Hasan. 2011. Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells. Photodermatol. Photoimmunol. Photomed. 27: 97-107
35. Boenisch, O., M. Lopez, W. Elyaman, C. N. Magee, U. Ahmad, and N. Najafian. 2012. Ex vivo expansion of human Tregs by rabbit ATG is dependent on intact STAT3-signaling in CD4+ T cells and requires the presence of monocytes. Am. J. Transplant. 12: 856-866
36. Liu, G., K. Duan, H. Ma, Z. Niu, J. Peng, and Y. Zhao. 2011. An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4+ Foxp3+ Treg cells. Immunol. Cell Biol. 89: 827-835
37. Coleman, M. M., D. Ruane, B. Moran, P. J. Dunne, J. Keane, and K. H. Mills. 2013. Alveolar macrophages contribute to respiratory tolerance by inducing FoxP3 expression in naive T cells. Am. J. Respir. Cell Mol. Biol. 48: 773-780
38. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341
39. Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8: 191-197
40. Aggarwal, N. R., F. R. D?Alessio, K. Tsushima, D. C. Files, M. Damarla, V. K. Sidhaye, M. M. Fraig, V. Y. Polotsky, and L. S. King. 2010. Moderate oxygen augments lipopolysaccharide-induced lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 298: L371-L381
41. Halbower, A. C., R. J. Mason, S. H. Abman, and R. M. Tuder. 1994. Agarose infiltration improves morphology of cryostat sections of lung. Lab. Invest. 71: 149-153
42. D?Alessio, F. R., K. Tsushima, N. R. Aggarwal, J. R. Mock, Y. Eto, B. T. Garibaldi, D. C. Files, C. R. Avalos, J. V. Rodriguez, A. T. Waickman, et al. 2012. Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase. J. Immunol. 189: 2234-2245
43. Matute-Bello, G., C. W. Frevert, and T. R. Martin. 2008. Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L379-L399
44. Martin, T. R., M. Nakamura, and G. Matute-Bello. 2003. The role of apoptosis in acute lung injury. Crit. Care Med. 31(Suppl. 4): S184-S188
45. Matute-Bello, G., W. C. Liles, F. Radella, II, K. P. Steinberg, J. T. Ruzinski, M. Jonas, E. Y. Chi, L. D. Hudson, and T. R. Martin. 1997. Neutrophil apoptosis in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 156: 1969-1977
46. Matute-Bello, G., and T. R. Martin. 2003. Science review: Apoptosis in acute lung injury. Crit. Care 7: 355-358
47. Narasaraju, T., E. Yang, R. P. Samy, H. H. Ng, W. P. Poh, A. A. Liew, M. C. Phoon, N. Van Rooijen, and V. T. Chow. 2011. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 179: 199-210
48. Maus, U., S. Rosseau, U. Knies, W. Seeger, and J. Lohmeyer. 1998. Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia. Eur. Respir. J. 11: 534-541
49. Park, W. Y., R. B. Goodman, K. P. Steinberg, J. T. Ruzinski, F. Radella, II, D. R. Park, J. Pugin, S. J. Skerrett, L. D. Hudson, and T. R. Martin. 2001. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 164: 1896-1903
50. Van Den Berg, J. M., S. Weyer, J. J. Weening, D. Roos, and T. W. Kuijpers. 2001. Divergent effects of tumor necrosis factor a on apoptosis of human neutrophils. J. Leukoc. Biol. 69: 467-473
51. Turina, M., J. J. Hoth, R. M. Turpen, M. J. Scott, and W. G. Cheadle. 2007. Alveolar interleukin-10 regulates neutrophil apoptosis in severely traumatized patients. J. Trauma 63: 733-739
52. Aggarwal, N. R., F. R. D?Alessio, Y. Eto, E. Chau, C. Avalos, A. T. Waickman, B. T. Garibaldi, J. R. Mock, D. C. Files, V. Sidhaye, et al. 2013. Macrophage A2A adenosinergic receptor modulates oxygen-induced augmentation of murine lung injury. Am. J. Respir. Cell Mol. Biol. 48: 635-646
53. Janssen, W. J., L. Barthel, A. Muldrow, R. E. Oberley-Deegan, M. T. Kearns, C. Jakubzick, and P. M. Henson. 2011. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 184: 547-560
54. Zaynagetdinov, R., T. P. Sherrill, P. L. Kendall, B. H. Segal, K. P. Weller, R. M. Tighe, and T. S. Blackwell. 2013. Identification of myeloid cell subsets in murine lungs using flow cytometry. Am. J. Respir. Cell Mol. Biol. 49: 180-189
55. Krieg, A. M. 2007. Antiinfective applications of Toll-like receptor 9 agonists. Proc. Am. Thorac. Soc. 4: 289-294
56. Spight, D., B. Zhao, M. Haas, S. Wert, A. Denenberg, and T. P. Shanley. 2005. Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L251-L265
57. Cuzzocrea, S., E. Mazzon, L. Dugo, I. Serraino, R. Di Paola, T. Genovese, A. De Sarro, and A. P. Caputi. 2002. Absence of endogenous interleukin-10 enhances the evolution of acute lung injury. Eur. Cytokine Netw. 13: 285-297
58. Kobbe, P., J. Schmidt, B. Stoffels, R. S. ChanthaphaVong, A. J. Bauer, and H. C. Pape. 2009. IL-10 administration attenuates pulmonary neutrophil infiltration and alters pulmonary iNOS activation following hemorrhagic shock. Inflamm. Res. 58: 170-174.
59. Kobbe, P., B. Stoffels, J. Schmidt, T. Tsukamoto, D. W. Gutkin, A. J. Bauer, and H. C. Pape. 2009. IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock. Cytokine 45: 26-31
60. Sun, L., R. F. Guo, M. W. Newstead, T. J. Standiford, D. R. Macariola, and T. P. Shanley. 2009. Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge. Am. J. Respir. Cell Mol. Biol. 41: 76-84
61. Van Der Sluijs, K. F., L. J. Van Elden, M. Nijhuis, R. Schuurman, J. M. Pater, S. Florquin, M. Goldman, H. M. Jansen, R. Lutter, and T.Van Der Poll. 2004. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J. Immunol. 172: 7603-7609
62. Johnston, L. K., C. R. Rims, S. E. Gill, J. K. McGuire, and A. M. Manicone. 2012. Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. Am. J. Respir. Cell Mol. Biol. 47: 417-426
63. Misharin, A. V., L. Morales-Nebreda, G. M. Mutlu, G. R. Budinger, and H. Perlman. 2013. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am. J. Respir. Cell Mol. Biol. 49: 503-510
64. Matute-Bello, G., W. C. Liles, F. Radella, II, K. P. Steinberg, J. T. Ruzinski, L. D. Hudson, and T. R. Martin. 2000. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colonystimulating factor during the course of acute respiratory distress syndrome. Crit. Care Med. 28: 1-7
65. Schreiner, J., D. Kretschmer, J. Klenk, M. Otto, H. J. Buhring, S. SteVanovic, J. M. Wang, S. Beer-Hammer, A. Peschel, and S. E. Autenrieth. 2013. Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J. Immunol. 190: 3417-3426
66. Poe, S. L., M. Arora, T. B. Oriss, M. Yarlagadda, K. Isse, A. Khare, D. E. Levy, J. S. Lee, R. K. Mallampalli, Y. R. Chan, et al. 2013. STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with releVance in resolution of bacterial pneumonia. Mucosal Immunol. 6: 189-199
67. Foster, S. L., and R. Medzhitov. 2009. Gene-specific control of the TLR-induced inflammatory response. Clin. Immunol. 130: 7-15
68. Fan, H., and J. A. Cook. 2004. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10: 71-84
69. Cross, A. S. 2002. Endotoxin tolerance-current concepts in historical perspective. J. Endotoxin Res. 8: 83-98
70. Cavaillon, J. M., and M. Adib-Conquy. 2006. Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10: 233
71. Cavaillon, J. M., C. Adrie, C. Fitting, and M. Adib-Conquy. 2003. Endotoxin tolerance: Is there a clinical releVance? J. Endotoxin Res. 9: 101-107
72. Medvedev, A. E., K. M. Kopydlowski, and S. N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J. Immunol. 164: 5564-5574
73. Dobrovolskaia, M. A., and S. N. Vogel. 2002. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4: 903-914
74. Mages, J., H. Dietrich, and R. Lang. 2007. A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 212: 723-737
75. Bagchi, A., E. A. Herrup, H. S. Warren, J. Trigilio, H. S. Shin, C. Valentine, and J. Hellman. 2007. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 178: 1164-1171
76. Dobrovolskaia, M. A., A. E. Medvedev, K. E. Thomas, N. Cuesta, V. Toshchakov, T. Ren, M. J. Cody, S. M. Michalek, N. R. Rice, and S. N. Vogel. 2003. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: Effects of TLR homotolerance versus heterotolerance on NF-kB signaling pathway components. J. Immunol. 170: 508-519
77. Sato, S., F. Nomura, T. Kawai, O. Takeuchi, P. F. Muhlradt, K. Takeda, and S. Akira. 2000. Synergy and cross-tolerance between Toll-like receptor (TLR)2-and TLR4-mediated signaling pathways. J. Immunol. 165: 7096-7101
78. Blackwell, T. S., T. R. Blackwell, and J. W. Christman. 1997. Induction of endotoxin tolerance depletes nuclear factor-kB and suppresses its activation in rat alveolar macrophages. J. Leukoc. Biol. 62: 885-891
79. Blackwell, T. S., T. R. Blackwell, and J.W. Christman. 1997. Impaired activation of nuclear factor-kB in endotoxin-tolerant rats is associated with downregulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J. Immunol. 158: 5934-5940
80. Elssner, A., A. I. Doseff, M. Duncan, M. Kotur, and M. D. Wewers. 2004. IL-16 is constitutively present in peripheral blood monocytes and spontaneously released during apoptosis. J. Immunol. 172: 7721-7725
81. McFadden, C., R. Morgan, S. Rahangdale, D. Green, H. Yamasaki, D. Center, andW. Cruikshank. 2007. Preferential migration of T regulatory cells induced by IL-16. J. Immunol. 179: 6439-6445
82. Collins, S. L., Y. Chan-Li, R. W. Hallowell, J. D. Powell, and M. R. Horton. 2012. Pulmonary vaccination as a novel treatment for lung fibrosis. PLoS One 7: E31299
83. Garibaldi, B. T., F. R. D?Alessio, J. R. Mock, D. C. Files, E. Chau, Y. Eto, M. B. Drummond, N. R. Aggarwal, V. Sidhaye, and L. S. King. 2013. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am. J. Respir. Cell Mol. Biol. 48: 35-43
84. Munger, J. S., X. Huang, H. Kawakatsu, M. J. Griffiths, S. L. Dalton, J. Wu, J. F. Pittet, N. Kaminski, C. Garat, M. A. Matthay, et al. 1999. The integrin avb6 binds and activates latent TGFb1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328
85. Bode, C., G. Zhao, F. Steinhagen, T. Kinjo, and D. M. Klinman. 2011. CpG DNA as a vaccine adjuVant. Expert Rev. Vaccines 10: 499-511
86. Jahrsdörfer, B., and G. J. Weiner. 2008. CpG oligodeoxynucleotides as immunotherapy in cancer. Update Cancer Ther. 3: 27-32